Stock AnalizAmrize Ltd AMRZ
Building Materials · IPO 2025 · data as of November 13, 2026
Amrize Ltd (AMRZ) is a industrial company listed in the US with a market value of about $21.8B. In the twelve months to September 30, 2026 it had revenue of $12.3B and net income of $1.3B, a net margin of 10.2%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is financial health (3/5); the weakest is future growth (1/5).
Key numbers: a P/E of 18.0, a price to free cash flow of 20.2, a 5-year average ROIC of 13%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 23% below the current price.
Score: 1.6 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- Profit margin improving
- 5-year average ROIC above 12%
- More cash than debt, or low debt to equity
- Positive free cash flow
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 3 years
| Fiscal year | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $12.3B | $11.8B | $11.7B | $11.7B |
| Net income | $1.3B | $1.2B | $1.3B | $956M |
| Free cash flow | $1.1B | $1.4B | $1.6B | $1.4B |
| EPS (diluted) | $2.27 | $2.14 | $2.30 | $1.73 |
| Net margin | 10.2% | 10.0% | 10.9% | 8.2% |
| ROIC | — | 7.8% | 16.3% | 14.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 19 analysts is $45.02, 10% above the current price; targets range from $32.00 to $55.00; the consensus rating is “Buy”; expected EPS is $2.29 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Amrize’s P/E ratio?
About 18.0, based on the last twelve months of diluted earnings per share (forward P/E about 25.3).
Is Amrize stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 23% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Amrize pay a dividend?
Yes. The dividend yield is about 1.06%.
Is Amrize a good stock to buy?
We do not give buy or sell advice. Amrize scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.